These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 25296889)
1. Why strategies to control Leishmania spp. multiplication based on the use of proteinase inhibitors should consider multiple targets and not only a single enzyme. Alves CR; Pereira BA; Silva-Almeida M; da Silva FS J Mol Model; 2014 Oct; 20(10):2465. PubMed ID: 25296889 [TBL] [Abstract][Full Text] [Related]
3. Natural products from Garcinia brasiliensis as Leishmania protease inhibitors. Pereira IO; Assis DM; Juliano MA; Cunha RL; Barbieri CL; do Sacramento LV; Marques MJ; dos Santos MH J Med Food; 2011 Jun; 14(6):557-62. PubMed ID: 21554130 [TBL] [Abstract][Full Text] [Related]
4. Computational and Investigative Study of Flavonoids Active Against Typanosoma cruzi and Leishmania spp. Ribeiro FF; Junior FJ; da Silva MS; Scotti MT; Scotti L Nat Prod Commun; 2015 Jun; 10(6):917-20. PubMed ID: 26197515 [TBL] [Abstract][Full Text] [Related]
5. Targeting tRNA-synthetase interactions towards novel therapeutic discovery against eukaryotic pathogens. Kelly P; Hadi-Nezhad F; Liu DY; Lawrence TJ; Linington RG; Ibba M; Ardell DH PLoS Negl Trop Dis; 2020 Feb; 14(2):e0007983. PubMed ID: 32106219 [TBL] [Abstract][Full Text] [Related]
6. Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening. Turcano L; Torrente E; Missineo A; Andreini M; Gramiccia M; Di Muccio T; Genovese I; Fiorillo A; Harper S; Bresciani A; Colotti G; Ilari A PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006969. PubMed ID: 30475811 [TBL] [Abstract][Full Text] [Related]
8. Effective Tetradentate Compound Complexes against Urbanová K; Ramírez-Macías I; Martín-Escolano R; Rosales MJ; Cussó O; Serrano J; Company A; Sánchez-Moreno M; Costas M; Ribas X; Marín C Molecules; 2018 Dec; 24(1):. PubMed ID: 30602705 [TBL] [Abstract][Full Text] [Related]
9. An Overview on Target-Based Drug Design against Kinetoplastid Protozoan Infections: Human African Trypanosomiasis, Chagas Disease and Leishmaniases. Kourbeli V; Chontzopoulou E; Moschovou K; Pavlos D; Mavromoustakos T; Papanastasiou IP Molecules; 2021 Jul; 26(15):. PubMed ID: 34361781 [TBL] [Abstract][Full Text] [Related]
10. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs. Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416 [TBL] [Abstract][Full Text] [Related]
11. Antileishmanial activity of novel indolyl-coumarin hybrids: Design, synthesis, biological evaluation, molecular docking study and in silico ADME prediction. Sangshetti JN; Kalam Khan FA; Kulkarni AA; Patil RH; Pachpinde AM; Lohar KS; Shinde DB Bioorg Med Chem Lett; 2016 Feb; 26(3):829-835. PubMed ID: 26778149 [TBL] [Abstract][Full Text] [Related]
12. Py-CoMFA, docking, and molecular dynamics simulations of Leishmania (L.) amazonensis arginase inhibitors. Camargo PG; Dos Santos CR; Girão Albuquerque M; Rangel Rodrigues C; Lima CHDS Sci Rep; 2024 May; 14(1):11575. PubMed ID: 38773273 [TBL] [Abstract][Full Text] [Related]
13. Synthesis and molecular modelling studies of phenyl linked oxadiazole-phenylhydrazone hybrids as potent antileishmanial agents. Taha M; Ismail NH; Imran S; Anouar EH; Selvaraj M; Jamil W; Ali M; Kashif SM; Rahim F; Khan KM; Adenan MI Eur J Med Chem; 2017 Jan; 126():1021-1033. PubMed ID: 28012342 [TBL] [Abstract][Full Text] [Related]
15. Optimization of dipeptidic inhibitors of cathepsin L for improved Toxoplasma gondii selectivity and CNS permeability. Zwicker JD; Diaz NA; Guerra AJ; Kirchhoff PD; Wen B; Sun D; Carruthers VB; Larsen SD Bioorg Med Chem Lett; 2018 Jun; 28(10):1972-1980. PubMed ID: 29650289 [TBL] [Abstract][Full Text] [Related]
16. Novel Thienopyrimidine Inhibitors of Bell AS; Yu Z; Hutton JA; Wright MH; Brannigan JA; Paape D; Roberts SM; Sutherell CL; Ritzefeld M; Wilkinson AJ; Smith DF; Leatherbarrow RJ; Tate EW J Med Chem; 2020 Jul; 63(14):7740-7765. PubMed ID: 32575985 [TBL] [Abstract][Full Text] [Related]
17. Mechanistic insights into mode of actions of novel oligopeptidase B inhibitors for combating leishmaniasis. Goyal S; Grover S; Dhanjal JK; Goyal M; Tyagi C; Chacko S; Grover A J Mol Model; 2014 Mar; 20(3):2099. PubMed ID: 24567150 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive review of chalcone derivatives as antileishmanial agents. de Mello MVP; Abrahim-Vieira BA; Domingos TFS; de Jesus JB; de Sousa ACC; Rodrigues CR; Souza AMT Eur J Med Chem; 2018 Apr; 150():920-929. PubMed ID: 29602038 [TBL] [Abstract][Full Text] [Related]